S.Amdt. 755

SA 755. Mr. MERKLEY submitted an amendment intended to be proposed by him to the bill H.R. 2430, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes; which was ordered to lie on the table; as follows:

At the end of title IX, insert the following:

SEC. 906. TOBACCO PRODUCTS.

Notwithstanding any other provision of law, the Commissioner of Food and Drugs may not delay the deadline, set forth in the rule entitled “Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products”, published May 10, 2016 (81 Fed. Reg. 28973), for submission of premarket tobacco product applications required for new tobacco products under section 910 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 387j).